AGAR Group

Menu

2023 Meetings

August 2023 Meeting:

AGAR EXECUTIVE MEETING AGENDA AUGUST 2023 (PDF)
2. AGAR Executive Meeting Minutes 10th August 2023 (PDF)
4.1. P aeuriginosa piptaz Vitek Performance (PDF)
4.2. Cairns AGAR 2023 Participation (PDF)
4.3. Collaboration Antibiotic Allergy and AGAR (PDF)
5. AGAR 2023 Operating Procedures (PDF)
6. 2023 AGAR Data Governance and Managment Plan (PDF)
7.1. December 2022 AGAR Financial Report (PDF)
7.2. March 2023 AGAR Financial Report (PDF)
7.3. June 2023 AGAR Financial Report (PDF)
7.4. 2022/2023 AGAR Financial Report (PDF)
8.1. AGAR 2022 Program Budget (PDF)
8.2. AGAR ASSOP 2022 Final Report (PDF)
8.3. AGAR AESOP 2022 Final Report (PDF)
8.4. AGAR GNSOP 2022 Final Report (PDF)
9.1. AGAR 2023 Program Budget (PDF)
9.2.1. AGAR Covering Letter (PDF)
9.2.2. AGAR Progress Report (PDF)
9.2.3. AGAR 2023 Project Plan (PDF)
9.3. AGAR 2023 Data Submission Schedule (PDF)
11.1. AGAR Kids Data Structure (PDF)
11.2. AGAR Kids Additional Project Plan (PDF)
11.3. AGAR Kids Additional Project Agreement (PDF)
11.4. AGAR Kids Additional Project Progress Report June 2023 (PDF)
11.5. AGAR Kids Steering Group Meeting July 2023 - AGENDA (PDF)
11.6. AGAR Kids DRAFT Minutes - AGAR Kids Meeting Steering Group Feb 2023 (PDF)
11.7. AGAR Kids Request (PDF)
13.1. AURA AGAR 2021 Surveillance Outcome Programs (PDF)
14.1. AURA Program Partner Virtual Meeting Agenda - 2 December 2022 (PDF)
14.2. GNSOP Additional Projects Final Report (PDF)
14.3. AGAR 2022 Progress Report July to December 2022 (PDF)
14.4. AURA Meeting Update March 2023 (PDF)
14.5. AURA Program Partner Meeting Agenda 23 March 2023 (PDF)
14.6. Letter of Offer - AGAR 2023 One-off Project (PDF)
14.7. Senior Staff Change (PDF)
14.8. WHO Publication AMR Prevalence (PDF)
14.9. AMR Policy Section Director (PDF)
14.10. AURA Program Partner Virtual Meeting Agenda - 21 July 2023 (PDF)
17.1. SA Pathology M. Warner (PDF)
17.2. University of Canberra D. Niyangoda (PDF)
17.3. St George hospital R. Hettiarachchi (PDF)
17.4. University of Queensland M. Blaskovich (PDF)
17.5. Canberra Hospital P. Collignon (PDF)
17.6. Telethon Kids Institute T. Barnett (PDF)
17.7. The Westmead Institute S. Lynch (PDF)
18.1. Methodological Principles of Nationally Representative AMR Surveys (PDF)
18.2. CDC Covid 19 US Impact on Antimicrobial Resistance (PDF)
18.3. Covid will not result in increased AMR Collignon 2020 JAC Resist 1 (PDF)
19.1. Vitek Cefoxitin Screen (PDF)
19.2. OHSS Plan AGAR Response (PDF)
19.3. Additional Project Proposal - L. Cooley (PDF)

Copyright © 2004-2022 Australian Group on Antimicrobial Resistance (AGAR). Last Updated December 2017.